Can a multiple sclerosis drug protect eyesight in macular degeneration?
NCT ID NCT04292080
First seen Feb 04, 2026 · Last updated Apr 29, 2026 · Updated 12 times
Summary
This study tests whether an oral medication called dimethyl fumarate (Tecfidera) can safely slow the growth of geographic atrophy, a severe form of age-related macular degeneration that causes vision loss. About 90 adults aged 55–85 with geographic atrophy will take the drug daily for 12 months. Researchers will measure changes in the size of the damaged area in the eye and track any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION (AMD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Centre intercommunal de Créteil
RECRUITINGCréteil, Val De Marne, 94000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.